EUCTR2021-002984-23-AT进行中（未招募）1 期
Retrospective quantification of anti-SARS-CoV-2 antibody response after mRNA COVID-19 vaccine in patients treated with peritoneal dialysis
Medical University of Graz0 个研究点目标入组 50 人开始时间: 2021年7月19日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •18 to 90 years of age
- •End stage kidney disease patient undergoing peritoneal dialysis
- •Patient was scheduled to receive an approved SARS-CoV2 vaccine as part of their routinely performed care
- •Provided written informed consent for the Bio-Bank”
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 50
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 50
排除标准
- •No informed consent of the Bio-Bank” was obtained
研究者
相似试验
尚未招募
不适用
Monitoring the immune response of anti-SARS-CoV2 vaccinated individuals and COVID-19-positive patients – a prospective monocentric non-interventional observational studyU07.1U08.9COVID-19, virus identifiedPersonal history of COVID-19, unspecifiedDRKS00024551Städtisches Klinikum Dessau. Medizinische Hochschule Brandenburg Theodor Fontane700
已完成
不适用
ong-term evaluation of SARS-CoV-2 antibody assays using mild symptomatik patients07.1GU09.9GDRKS00028039DiaSys Diagnostic Systems GmbH21
进行中（未招募）
1 期
Detection and Characterization of Anti-SARS-CoV-2 Salivary Antibodies after COVID-19 Booster Vaccines – The CoVVacBoost Study - The CoVVacBoost StudyCovid (Coronavirus disease)- 19 immunisationMedDRA version: 23.1Level: PTClassification code 10084457Term: COVID-19 immunisationSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2021-006172-16-ATMedical University of Graz1,200
已完成
不适用
Investigation for the prevalence of anti-SARS-CoV-2 antibody.COVID-19JPRN-UMIN000046246Fukuoka City Hospital281
招募中
不适用
Cohort study of investigation of SARS-CoV-2 antibody after vaccination in patients with or without cancerCancerJPRN-UMIN000045571Kushiro Rosai Hospital100